Collegium Pharmaceutical, Inc.

Collegium Pharmaceutical Misses on EPS, Stock Down 4.16%

Collegium Pharmaceutical reported a larger-than-expected loss per share, which contributed to a 4.16% decline in its stock price. The lack of revenue figures and management commentary leaves investors with limited insights into the company's performance and future outlook. Overall, the earnings miss may raise concerns about the company's financial health and growth prospects.